Stevanato Group S.p.A. Stock (NYSE:STVN)


ForecastOwnershipChartTranscripts

Previous Close

$17.25

52W Range

$12.89 - $28.00

50D Avg

$16.80

200D Avg

$19.85

Market Cap

$4.72B

Avg Vol (3M)

$515.52K

Beta

0.78

Div Yield

$0.06 (0.36%)

STVN Company Profile


Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

IT

Employees

5,521

IPO Date

Jul 16, 2021

Website

STVN Performance


Latest Earnings Call Transcripts


Q1 26May 07, 26 | 12:00 AM
Q4 25Mar 04, 26 | 12:00 AM
Q3 25Nov 07, 25 | 8:30 AM

Peer Comparison


TickerCompany
AXSMAxsome Therapeutics, Inc.
ATRAptarGroup, Inc.
BTSGBrightSpring Health Services, Inc. Common Stock
MMSIMerit Medical Systems, Inc.
CHEChemed Corporation
TFXTeleflex Incorporated
AVTRAvantor, Inc.
BLCOBausch + Lomb Corporation
MASIMasimo Corporation
NUVLNuvalent, Inc.